Fradet Y - Search Results

1

Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder.

Allard P, Fradet Y, Têtu B, Bernard P. Allard P, et al. Among authors: fradet y. Clin Cancer Res. 1995 Oct;1(10):1195-202. Clin Cancer Res. 1995. PMID: 9815912

2

Strategies of chemoprevention based on antigenic and molecular markers of early and premalignant lesions of the bladder.

Fradet Y, Lafleur L, LaRue H. Fradet Y, et al. J Cell Biochem Suppl. 1992;16I:85-92. doi: 10.1002/jcb.240501319. J Cell Biochem Suppl. 1992. PMID: 1305695 Review.

3

Monoclonal antibody against a tumor-associated sialoglycoprotein of superficial papillary bladder tumors and cervical condylomas.

Fradet Y, LaRue H, Parent-Vaugeois C, Bergeron A, Dufour C, Boucher L, Bernier L. Fradet Y, et al. Int J Cancer. 1990 Dec 15;46(6):990-7. doi: 10.1002/ijc.2910460607. Int J Cancer. 1990. PMID: 1701166

4

Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group.

Fradet Y, Tardif M, Bourget L, Robert J. Fradet Y, et al. Cancer Res. 1990 Jan 15;50(2):432-7. Cancer Res. 1990. PMID: 2295082

5

Growth-regulated surface glycoproteins of human bladder cancer.

Gauthier J, Fradet Y. Gauthier J, et al. Among authors: fradet y. Cancer Res. 1990 Jan 15;50(2):293-8. Cancer Res. 1990. PMID: 2403838

Clinical studies of human bladder cancer cells with mouse monoclonal antibodies (mAbs) have revealed two surface glycoproteins (T43 and T138) expressed by aggressive cancers and not by normal cells and a differentiation antigen (T16) expressed by normal and tumor cells of urothel …

Clinical studies of human bladder cancer cells with mouse monoclonal antibodies (mAbs) have revealed two surface glycoproteins (T43 and T138 …

6

Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodies.

Fradet Y, Islam N, Boucher L, Parent-Vaugeois C, Tardif M. Fradet Y, et al. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7227-31. doi: 10.1073/pnas.84.20.7227. Proc Natl Acad Sci U S A. 1987. PMID: 3313389 Free PMC article.

7

Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics.

Fradet Y, Cordon-Cardo C, Whitmore WF Jr, Melamed MR, Old LJ. Fradet Y, et al. Cancer Res. 1986 Oct;46(10):5183-8. Cancer Res. 1986. PMID: 3756873

8

Downstaging by combination therapy with flutamide and an LHRH agonist before radical prostatectomy.

Labrie F, Cusan L, Gomez JL, Diamond P, Suburu R, Lemay M, Têtu B, Fradet Y, Candas B. Labrie F, et al. Among authors: fradet y. Cancer Surv. 1995;23:149-56. Cancer Surv. 1995. PMID: 7621455 Clinical Trial.

9

Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial.

Labrie F, Dupont A, Cusan L, Gomez J, Diamond P, Koutsilieris M, Suburu R, Fradet Y, Lemay M, Têtu B, et al. Labrie F, et al. Among authors: fradet y. Clin Invest Med. 1993 Dec;16(6):499-509. Clin Invest Med. 1993. PMID: 8013155 Clinical Trial.

10

Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy.

Van der Kwast TH, Têtu B, Fradet Y, Dupont A, Gomez J, Cusan L, Diamond P, Labrie F. Van der Kwast TH, et al. Among authors: fradet y. Prostate. 1996 Apr;28(4):227-31. doi: 10.1002/(SICI)1097-0045(199604)28:4<227::AID-PROS3>3.0.CO;2-A. Prostate. 1996. PMID: 8602398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters